MultiHance® 9 Image Library 9 Colosimo et al. 50M Metastatic Renal Carcinoma

MultiHance® (gadobenate dimeglumine) injection, 529 mg/mL Improves Visualization and Enhancement of Lesions vs. Dotarem® (gadoterate meglumine)1

Colosimo et al.
50-year-old man with metastatic renal carcinoma

These are representative images from reference studies; individual results may vary.
Reference: 1. Colosimo C, Knopp MV, Barreau X, et al. A comparison of Gd-BOPTA and Gd-DOTA for contrast-enhanced MRI of intracranial tumours. Neuroradiology. 2004;46(8):655-665.

View Full Image Library

More cases that may interest you

Seidl et al. 70M Metastatic Lung Carcinoma

Seidl et al. 70M Metastatic Lung Carcinoma

Seidl et al. 58F Metastatic Melanoma

Seidl et al. 58F Metastatic Melanoma

Rowley et al. 55F Glioblastoma with Recurrent Disease

Rowley et al. 55F Glioblastoma with Recurrent Disease